nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Vincristine—sarcoma	0.272	0.42	CbGbCtD
Bosentan—ABCB11—Doxorubicin—sarcoma	0.17	0.262	CbGbCtD
Bosentan—CYP3A4—Thiotepa—sarcoma	0.0944	0.146	CbGbCtD
Bosentan—CYP3A4—Mitoxantrone—sarcoma	0.0406	0.0626	CbGbCtD
Bosentan—CYP3A4—Vincristine—sarcoma	0.0279	0.0431	CbGbCtD
Bosentan—CYP3A4—Etoposide—sarcoma	0.0256	0.0395	CbGbCtD
Bosentan—CYP3A4—Doxorubicin—sarcoma	0.0175	0.0269	CbGbCtD
Bosentan—EDNRB—mammary gland—sarcoma	0.00587	0.115	CbGeAlD
Bosentan—EDNRA—mammary gland—sarcoma	0.00485	0.0952	CbGeAlD
Bosentan—EDNRB—myometrium—sarcoma	0.00416	0.0817	CbGeAlD
Bosentan—EDNRA—myometrium—sarcoma	0.00344	0.0675	CbGeAlD
Bosentan—EDNRA—seminal vesicle—sarcoma	0.00311	0.061	CbGeAlD
Bosentan—EDNRB—cardiac atrium—sarcoma	0.00271	0.0533	CbGeAlD
Bosentan—EDNRB—uterus—sarcoma	0.0027	0.053	CbGeAlD
Bosentan—EDNRB—tendon—sarcoma	0.00236	0.0464	CbGeAlD
Bosentan—EDNRA—cardiac atrium—sarcoma	0.00224	0.044	CbGeAlD
Bosentan—EDNRA—uterus—sarcoma	0.00223	0.0438	CbGeAlD
Bosentan—EDNRB—testis—sarcoma	0.00196	0.0384	CbGeAlD
Bosentan—EDNRA—tendon—sarcoma	0.00195	0.0384	CbGeAlD
Bosentan—EDNRB—liver—sarcoma	0.00185	0.0363	CbGeAlD
Bosentan—EDNRA—testis—sarcoma	0.00162	0.0318	CbGeAlD
Bosentan—CYP2C9—mammary gland—sarcoma	0.0016	0.0315	CbGeAlD
Bosentan—ABCB11—testis—sarcoma	0.00158	0.031	CbGeAlD
Bosentan—ABCB11—liver—sarcoma	0.00149	0.0293	CbGeAlD
Bosentan—EDNRB—lymph node—sarcoma	0.00142	0.0279	CbGeAlD
Bosentan—EDNRA—lymph node—sarcoma	0.00117	0.023	CbGeAlD
Bosentan—CYP2C9—hematopoietic system—sarcoma	0.000977	0.0192	CbGeAlD
Bosentan—CYP3A4—hematopoietic system—sarcoma	0.000745	0.0146	CbGeAlD
Bosentan—CYP2C9—liver—sarcoma	0.000506	0.00994	CbGeAlD
Bosentan—CYP3A4—liver—sarcoma	0.000386	0.00758	CbGeAlD
Bosentan—Angina pectoris—Epirubicin—sarcoma	0.000333	0.0011	CcSEcCtD
Bosentan—Urticaria—Mitoxantrone—sarcoma	0.000331	0.0011	CcSEcCtD
Bosentan—Anorexia—Etoposide—sarcoma	0.00033	0.0011	CcSEcCtD
Bosentan—Diarrhoea—Thiotepa—sarcoma	0.00033	0.0011	CcSEcCtD
Bosentan—Body temperature increased—Mitoxantrone—sarcoma	0.000329	0.00109	CcSEcCtD
Bosentan—Abdominal pain—Mitoxantrone—sarcoma	0.000329	0.00109	CcSEcCtD
Bosentan—Bronchitis—Epirubicin—sarcoma	0.000328	0.00109	CcSEcCtD
Bosentan—Diarrhoea—Dactinomycin—sarcoma	0.000327	0.00109	CcSEcCtD
Bosentan—Nasopharyngitis—Doxorubicin—sarcoma	0.000327	0.00109	CcSEcCtD
Bosentan—Hypotension—Etoposide—sarcoma	0.000324	0.00107	CcSEcCtD
Bosentan—Dysuria—Epirubicin—sarcoma	0.000319	0.00106	CcSEcCtD
Bosentan—Neutropenia—Epirubicin—sarcoma	0.000319	0.00106	CcSEcCtD
Bosentan—Dizziness—Thiotepa—sarcoma	0.000319	0.00106	CcSEcCtD
Bosentan—Abdominal distension—Doxorubicin—sarcoma	0.000318	0.00106	CcSEcCtD
Bosentan—Upper respiratory tract infection—Epirubicin—sarcoma	0.000317	0.00105	CcSEcCtD
Bosentan—Asthma—Doxorubicin—sarcoma	0.000316	0.00105	CcSEcCtD
Bosentan—Influenza—Doxorubicin—sarcoma	0.000316	0.00105	CcSEcCtD
Bosentan—Pollakiuria—Epirubicin—sarcoma	0.000315	0.00105	CcSEcCtD
Bosentan—Hypersensitivity—Vincristine—sarcoma	0.000315	0.00105	CcSEcCtD
Bosentan—Eosinophilia—Doxorubicin—sarcoma	0.000313	0.00104	CcSEcCtD
Bosentan—Paraesthesia—Etoposide—sarcoma	0.000311	0.00103	CcSEcCtD
Bosentan—Weight increased—Epirubicin—sarcoma	0.000311	0.00103	CcSEcCtD
Bosentan—Weight decreased—Epirubicin—sarcoma	0.000309	0.00103	CcSEcCtD
Bosentan—Dyspnoea—Etoposide—sarcoma	0.000309	0.00103	CcSEcCtD
Bosentan—Hyperglycaemia—Epirubicin—sarcoma	0.000308	0.00102	CcSEcCtD
Bosentan—Somnolence—Etoposide—sarcoma	0.000308	0.00102	CcSEcCtD
Bosentan—Angina pectoris—Doxorubicin—sarcoma	0.000308	0.00102	CcSEcCtD
Bosentan—Hypersensitivity—Mitoxantrone—sarcoma	0.000307	0.00102	CcSEcCtD
Bosentan—Asthenia—Vincristine—sarcoma	0.000307	0.00102	CcSEcCtD
Bosentan—Vomiting—Thiotepa—sarcoma	0.000307	0.00102	CcSEcCtD
Bosentan—Pneumonia—Epirubicin—sarcoma	0.000306	0.00102	CcSEcCtD
Bosentan—Infestation NOS—Epirubicin—sarcoma	0.000304	0.00101	CcSEcCtD
Bosentan—Infestation—Epirubicin—sarcoma	0.000304	0.00101	CcSEcCtD
Bosentan—Vomiting—Dactinomycin—sarcoma	0.000304	0.00101	CcSEcCtD
Bosentan—Rash—Thiotepa—sarcoma	0.000304	0.00101	CcSEcCtD
Bosentan—Bronchitis—Doxorubicin—sarcoma	0.000304	0.00101	CcSEcCtD
Bosentan—Dermatitis—Thiotepa—sarcoma	0.000304	0.00101	CcSEcCtD
Bosentan—Headache—Thiotepa—sarcoma	0.000302	0.001	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000302	0.001	CcSEcCtD
Bosentan—Rash—Dactinomycin—sarcoma	0.000302	0.001	CcSEcCtD
Bosentan—Decreased appetite—Etoposide—sarcoma	0.000301	0.001	CcSEcCtD
Bosentan—Renal failure—Epirubicin—sarcoma	0.000299	0.000993	CcSEcCtD
Bosentan—Gastrointestinal disorder—Etoposide—sarcoma	0.000299	0.000993	CcSEcCtD
Bosentan—Asthenia—Mitoxantrone—sarcoma	0.000299	0.000992	CcSEcCtD
Bosentan—Fatigue—Etoposide—sarcoma	0.000299	0.000991	CcSEcCtD
Bosentan—Stomatitis—Epirubicin—sarcoma	0.000297	0.000985	CcSEcCtD
Bosentan—Jaundice—Epirubicin—sarcoma	0.000297	0.000985	CcSEcCtD
Bosentan—Pain—Etoposide—sarcoma	0.000296	0.000983	CcSEcCtD
Bosentan—Constipation—Etoposide—sarcoma	0.000296	0.000983	CcSEcCtD
Bosentan—Urinary tract infection—Epirubicin—sarcoma	0.000296	0.000982	CcSEcCtD
Bosentan—Conjunctivitis—Epirubicin—sarcoma	0.000296	0.000982	CcSEcCtD
Bosentan—Neutropenia—Doxorubicin—sarcoma	0.000295	0.000981	CcSEcCtD
Bosentan—Dysuria—Doxorubicin—sarcoma	0.000295	0.000981	CcSEcCtD
Bosentan—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000294	0.000975	CcSEcCtD
Bosentan—Diarrhoea—Vincristine—sarcoma	0.000293	0.000971	CcSEcCtD
Bosentan—Pollakiuria—Doxorubicin—sarcoma	0.000292	0.000969	CcSEcCtD
Bosentan—Haematuria—Epirubicin—sarcoma	0.00029	0.000964	CcSEcCtD
Bosentan—Hepatobiliary disease—Epirubicin—sarcoma	0.000288	0.000956	CcSEcCtD
Bosentan—Weight increased—Doxorubicin—sarcoma	0.000288	0.000954	CcSEcCtD
Bosentan—Epistaxis—Epirubicin—sarcoma	0.000287	0.000953	CcSEcCtD
Bosentan—Nausea—Thiotepa—sarcoma	0.000286	0.000951	CcSEcCtD
Bosentan—Weight decreased—Doxorubicin—sarcoma	0.000286	0.000949	CcSEcCtD
Bosentan—Sinusitis—Epirubicin—sarcoma	0.000286	0.000948	CcSEcCtD
Bosentan—Hyperglycaemia—Doxorubicin—sarcoma	0.000285	0.000946	CcSEcCtD
Bosentan—Diarrhoea—Mitoxantrone—sarcoma	0.000285	0.000946	CcSEcCtD
Bosentan—Nausea—Dactinomycin—sarcoma	0.000284	0.000944	CcSEcCtD
Bosentan—Pneumonia—Doxorubicin—sarcoma	0.000283	0.000941	CcSEcCtD
Bosentan—Gastrointestinal pain—Etoposide—sarcoma	0.000283	0.00094	CcSEcCtD
Bosentan—Dizziness—Vincristine—sarcoma	0.000283	0.000939	CcSEcCtD
Bosentan—Infestation NOS—Doxorubicin—sarcoma	0.000282	0.000935	CcSEcCtD
Bosentan—Infestation—Doxorubicin—sarcoma	0.000282	0.000935	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000279	0.000927	CcSEcCtD
Bosentan—Bradycardia—Epirubicin—sarcoma	0.000278	0.000924	CcSEcCtD
Bosentan—Renal failure—Doxorubicin—sarcoma	0.000277	0.000919	CcSEcCtD
Bosentan—Urticaria—Etoposide—sarcoma	0.000275	0.000913	CcSEcCtD
Bosentan—Haemoglobin—Epirubicin—sarcoma	0.000275	0.000912	CcSEcCtD
Bosentan—Stomatitis—Doxorubicin—sarcoma	0.000275	0.000911	CcSEcCtD
Bosentan—Jaundice—Doxorubicin—sarcoma	0.000275	0.000911	CcSEcCtD
Bosentan—Abdominal pain—Etoposide—sarcoma	0.000274	0.000909	CcSEcCtD
Bosentan—Body temperature increased—Etoposide—sarcoma	0.000274	0.000909	CcSEcCtD
Bosentan—Conjunctivitis—Doxorubicin—sarcoma	0.000274	0.000909	CcSEcCtD
Bosentan—Urinary tract infection—Doxorubicin—sarcoma	0.000274	0.000909	CcSEcCtD
Bosentan—Haemorrhage—Epirubicin—sarcoma	0.000273	0.000907	CcSEcCtD
Bosentan—Hepatitis—Epirubicin—sarcoma	0.000273	0.000907	CcSEcCtD
Bosentan—Hypoaesthesia—Epirubicin—sarcoma	0.000272	0.000903	CcSEcCtD
Bosentan—Vomiting—Vincristine—sarcoma	0.000272	0.000903	CcSEcCtD
Bosentan—Urinary tract disorder—Epirubicin—sarcoma	0.00027	0.000896	CcSEcCtD
Bosentan—Rash—Vincristine—sarcoma	0.00027	0.000895	CcSEcCtD
Bosentan—Dermatitis—Vincristine—sarcoma	0.000269	0.000894	CcSEcCtD
Bosentan—Oedema peripheral—Epirubicin—sarcoma	0.000269	0.000894	CcSEcCtD
Bosentan—Haematuria—Doxorubicin—sarcoma	0.000269	0.000892	CcSEcCtD
Bosentan—Urethral disorder—Epirubicin—sarcoma	0.000268	0.000889	CcSEcCtD
Bosentan—Headache—Vincristine—sarcoma	0.000268	0.000889	CcSEcCtD
Bosentan—Hepatobiliary disease—Doxorubicin—sarcoma	0.000266	0.000884	CcSEcCtD
Bosentan—Epistaxis—Doxorubicin—sarcoma	0.000266	0.000882	CcSEcCtD
Bosentan—Vomiting—Mitoxantrone—sarcoma	0.000265	0.000879	CcSEcCtD
Bosentan—Sinusitis—Doxorubicin—sarcoma	0.000264	0.000877	CcSEcCtD
Bosentan—Rash—Mitoxantrone—sarcoma	0.000263	0.000872	CcSEcCtD
Bosentan—Dermatitis—Mitoxantrone—sarcoma	0.000262	0.000871	CcSEcCtD
Bosentan—Headache—Mitoxantrone—sarcoma	0.000261	0.000866	CcSEcCtD
Bosentan—Erythema multiforme—Epirubicin—sarcoma	0.000258	0.000858	CcSEcCtD
Bosentan—Bradycardia—Doxorubicin—sarcoma	0.000257	0.000855	CcSEcCtD
Bosentan—Eye disorder—Epirubicin—sarcoma	0.000255	0.000848	CcSEcCtD
Bosentan—Hypersensitivity—Etoposide—sarcoma	0.000255	0.000847	CcSEcCtD
Bosentan—Tinnitus—Epirubicin—sarcoma	0.000255	0.000846	CcSEcCtD
Bosentan—Haemoglobin—Doxorubicin—sarcoma	0.000254	0.000844	CcSEcCtD
Bosentan—Nausea—Vincristine—sarcoma	0.000254	0.000843	CcSEcCtD
Bosentan—Flushing—Epirubicin—sarcoma	0.000254	0.000842	CcSEcCtD
Bosentan—Cardiac disorder—Epirubicin—sarcoma	0.000254	0.000842	CcSEcCtD
Bosentan—Hepatitis—Doxorubicin—sarcoma	0.000253	0.000839	CcSEcCtD
Bosentan—Haemorrhage—Doxorubicin—sarcoma	0.000253	0.000839	CcSEcCtD
Bosentan—Hypoaesthesia—Doxorubicin—sarcoma	0.000252	0.000835	CcSEcCtD
Bosentan—Urinary tract disorder—Doxorubicin—sarcoma	0.00025	0.000829	CcSEcCtD
Bosentan—Oedema peripheral—Doxorubicin—sarcoma	0.000249	0.000827	CcSEcCtD
Bosentan—Asthenia—Etoposide—sarcoma	0.000249	0.000825	CcSEcCtD
Bosentan—Angiopathy—Epirubicin—sarcoma	0.000248	0.000823	CcSEcCtD
Bosentan—Urethral disorder—Doxorubicin—sarcoma	0.000248	0.000823	CcSEcCtD
Bosentan—Nausea—Mitoxantrone—sarcoma	0.000247	0.000821	CcSEcCtD
Bosentan—Immune system disorder—Epirubicin—sarcoma	0.000247	0.000819	CcSEcCtD
Bosentan—Mediastinal disorder—Epirubicin—sarcoma	0.000246	0.000818	CcSEcCtD
Bosentan—Chills—Epirubicin—sarcoma	0.000245	0.000814	CcSEcCtD
Bosentan—Pruritus—Etoposide—sarcoma	0.000245	0.000814	CcSEcCtD
Bosentan—Mental disorder—Epirubicin—sarcoma	0.000239	0.000795	CcSEcCtD
Bosentan—Erythema multiforme—Doxorubicin—sarcoma	0.000239	0.000794	CcSEcCtD
Bosentan—Malnutrition—Epirubicin—sarcoma	0.000238	0.00079	CcSEcCtD
Bosentan—Erythema—Epirubicin—sarcoma	0.000238	0.00079	CcSEcCtD
Bosentan—Diarrhoea—Etoposide—sarcoma	0.000237	0.000787	CcSEcCtD
Bosentan—Eye disorder—Doxorubicin—sarcoma	0.000236	0.000784	CcSEcCtD
Bosentan—Tinnitus—Doxorubicin—sarcoma	0.000236	0.000783	CcSEcCtD
Bosentan—Flushing—Doxorubicin—sarcoma	0.000235	0.000779	CcSEcCtD
Bosentan—Cardiac disorder—Doxorubicin—sarcoma	0.000235	0.000779	CcSEcCtD
Bosentan—Flatulence—Epirubicin—sarcoma	0.000234	0.000778	CcSEcCtD
Bosentan—Back pain—Epirubicin—sarcoma	0.00023	0.000764	CcSEcCtD
Bosentan—Angiopathy—Doxorubicin—sarcoma	0.000229	0.000762	CcSEcCtD
Bosentan—Dizziness—Etoposide—sarcoma	0.000229	0.00076	CcSEcCtD
Bosentan—Muscle spasms—Epirubicin—sarcoma	0.000229	0.000759	CcSEcCtD
Bosentan—Immune system disorder—Doxorubicin—sarcoma	0.000228	0.000758	CcSEcCtD
Bosentan—Mediastinal disorder—Doxorubicin—sarcoma	0.000228	0.000757	CcSEcCtD
Bosentan—Chills—Doxorubicin—sarcoma	0.000227	0.000753	CcSEcCtD
Bosentan—Vision blurred—Epirubicin—sarcoma	0.000224	0.000744	CcSEcCtD
Bosentan—Mental disorder—Doxorubicin—sarcoma	0.000222	0.000735	CcSEcCtD
Bosentan—Vomiting—Etoposide—sarcoma	0.00022	0.000731	CcSEcCtD
Bosentan—Malnutrition—Doxorubicin—sarcoma	0.00022	0.000731	CcSEcCtD
Bosentan—Erythema—Doxorubicin—sarcoma	0.00022	0.000731	CcSEcCtD
Bosentan—Anaemia—Epirubicin—sarcoma	0.00022	0.00073	CcSEcCtD
Bosentan—Rash—Etoposide—sarcoma	0.000218	0.000725	CcSEcCtD
Bosentan—Dermatitis—Etoposide—sarcoma	0.000218	0.000724	CcSEcCtD
Bosentan—Headache—Etoposide—sarcoma	0.000217	0.00072	CcSEcCtD
Bosentan—Flatulence—Doxorubicin—sarcoma	0.000217	0.00072	CcSEcCtD
Bosentan—Vertigo—Epirubicin—sarcoma	0.000214	0.00071	CcSEcCtD
Bosentan—Syncope—Epirubicin—sarcoma	0.000213	0.000708	CcSEcCtD
Bosentan—Leukopenia—Epirubicin—sarcoma	0.000213	0.000707	CcSEcCtD
Bosentan—Back pain—Doxorubicin—sarcoma	0.000213	0.000707	CcSEcCtD
Bosentan—Muscle spasms—Doxorubicin—sarcoma	0.000212	0.000703	CcSEcCtD
Bosentan—Palpitations—Epirubicin—sarcoma	0.00021	0.000698	CcSEcCtD
Bosentan—Loss of consciousness—Epirubicin—sarcoma	0.000209	0.000694	CcSEcCtD
Bosentan—Cough—Epirubicin—sarcoma	0.000208	0.000689	CcSEcCtD
Bosentan—Vision blurred—Doxorubicin—sarcoma	0.000207	0.000689	CcSEcCtD
Bosentan—Nausea—Etoposide—sarcoma	0.000206	0.000683	CcSEcCtD
Bosentan—Anaemia—Doxorubicin—sarcoma	0.000203	0.000675	CcSEcCtD
Bosentan—Arthralgia—Epirubicin—sarcoma	0.000203	0.000672	CcSEcCtD
Bosentan—Chest pain—Epirubicin—sarcoma	0.000203	0.000672	CcSEcCtD
Bosentan—Anxiety—Epirubicin—sarcoma	0.000202	0.00067	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000201	0.000668	CcSEcCtD
Bosentan—Discomfort—Epirubicin—sarcoma	0.0002	0.000664	CcSEcCtD
Bosentan—Dry mouth—Epirubicin—sarcoma	0.000198	0.000658	CcSEcCtD
Bosentan—Vertigo—Doxorubicin—sarcoma	0.000198	0.000657	CcSEcCtD
Bosentan—Syncope—Doxorubicin—sarcoma	0.000197	0.000655	CcSEcCtD
Bosentan—Leukopenia—Doxorubicin—sarcoma	0.000197	0.000654	CcSEcCtD
Bosentan—Palpitations—Doxorubicin—sarcoma	0.000195	0.000646	CcSEcCtD
Bosentan—Oedema—Epirubicin—sarcoma	0.000194	0.000645	CcSEcCtD
Bosentan—Anaphylactic shock—Epirubicin—sarcoma	0.000194	0.000645	CcSEcCtD
Bosentan—Loss of consciousness—Doxorubicin—sarcoma	0.000193	0.000642	CcSEcCtD
Bosentan—Infection—Epirubicin—sarcoma	0.000193	0.00064	CcSEcCtD
Bosentan—Cough—Doxorubicin—sarcoma	0.000192	0.000638	CcSEcCtD
Bosentan—Shock—Epirubicin—sarcoma	0.000191	0.000634	CcSEcCtD
Bosentan—Nervous system disorder—Epirubicin—sarcoma	0.00019	0.000632	CcSEcCtD
Bosentan—Thrombocytopenia—Epirubicin—sarcoma	0.00019	0.000631	CcSEcCtD
Bosentan—Tachycardia—Epirubicin—sarcoma	0.000189	0.000629	CcSEcCtD
Bosentan—Skin disorder—Epirubicin—sarcoma	0.000189	0.000626	CcSEcCtD
Bosentan—Hyperhidrosis—Epirubicin—sarcoma	0.000188	0.000623	CcSEcCtD
Bosentan—Arthralgia—Doxorubicin—sarcoma	0.000187	0.000622	CcSEcCtD
Bosentan—Chest pain—Doxorubicin—sarcoma	0.000187	0.000622	CcSEcCtD
Bosentan—Anxiety—Doxorubicin—sarcoma	0.000187	0.00062	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000186	0.000618	CcSEcCtD
Bosentan—Discomfort—Doxorubicin—sarcoma	0.000185	0.000615	CcSEcCtD
Bosentan—Anorexia—Epirubicin—sarcoma	0.000185	0.000614	CcSEcCtD
Bosentan—Dry mouth—Doxorubicin—sarcoma	0.000183	0.000608	CcSEcCtD
Bosentan—Hypotension—Epirubicin—sarcoma	0.000181	0.000602	CcSEcCtD
Bosentan—Oedema—Doxorubicin—sarcoma	0.00018	0.000596	CcSEcCtD
Bosentan—Anaphylactic shock—Doxorubicin—sarcoma	0.00018	0.000596	CcSEcCtD
Bosentan—Infection—Doxorubicin—sarcoma	0.000178	0.000592	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000177	0.000587	CcSEcCtD
Bosentan—Shock—Doxorubicin—sarcoma	0.000177	0.000587	CcSEcCtD
Bosentan—Nervous system disorder—Doxorubicin—sarcoma	0.000176	0.000585	CcSEcCtD
Bosentan—Thrombocytopenia—Doxorubicin—sarcoma	0.000176	0.000584	CcSEcCtD
Bosentan—Insomnia—Epirubicin—sarcoma	0.000176	0.000583	CcSEcCtD
Bosentan—Tachycardia—Doxorubicin—sarcoma	0.000175	0.000582	CcSEcCtD
Bosentan—Skin disorder—Doxorubicin—sarcoma	0.000175	0.000579	CcSEcCtD
Bosentan—Paraesthesia—Epirubicin—sarcoma	0.000174	0.000579	CcSEcCtD
Bosentan—Hyperhidrosis—Doxorubicin—sarcoma	0.000174	0.000577	CcSEcCtD
Bosentan—Dyspnoea—Epirubicin—sarcoma	0.000173	0.000575	CcSEcCtD
Bosentan—Somnolence—Epirubicin—sarcoma	0.000173	0.000573	CcSEcCtD
Bosentan—Anorexia—Doxorubicin—sarcoma	0.000171	0.000568	CcSEcCtD
Bosentan—Dyspepsia—Epirubicin—sarcoma	0.000171	0.000567	CcSEcCtD
Bosentan—Decreased appetite—Epirubicin—sarcoma	0.000169	0.00056	CcSEcCtD
Bosentan—Hypotension—Doxorubicin—sarcoma	0.000168	0.000557	CcSEcCtD
Bosentan—Gastrointestinal disorder—Epirubicin—sarcoma	0.000168	0.000556	CcSEcCtD
Bosentan—Fatigue—Epirubicin—sarcoma	0.000167	0.000556	CcSEcCtD
Bosentan—Pain—Epirubicin—sarcoma	0.000166	0.000551	CcSEcCtD
Bosentan—Constipation—Epirubicin—sarcoma	0.000166	0.000551	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000164	0.000543	CcSEcCtD
Bosentan—Insomnia—Doxorubicin—sarcoma	0.000162	0.000539	CcSEcCtD
Bosentan—Paraesthesia—Doxorubicin—sarcoma	0.000161	0.000536	CcSEcCtD
Bosentan—Dyspnoea—Doxorubicin—sarcoma	0.00016	0.000532	CcSEcCtD
Bosentan—Somnolence—Doxorubicin—sarcoma	0.00016	0.00053	CcSEcCtD
Bosentan—Gastrointestinal pain—Epirubicin—sarcoma	0.000159	0.000527	CcSEcCtD
Bosentan—Dyspepsia—Doxorubicin—sarcoma	0.000158	0.000525	CcSEcCtD
Bosentan—Decreased appetite—Doxorubicin—sarcoma	0.000156	0.000518	CcSEcCtD
Bosentan—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000155	0.000515	CcSEcCtD
Bosentan—Fatigue—Doxorubicin—sarcoma	0.000155	0.000514	CcSEcCtD
Bosentan—Urticaria—Epirubicin—sarcoma	0.000154	0.000512	CcSEcCtD
Bosentan—Constipation—Doxorubicin—sarcoma	0.000154	0.00051	CcSEcCtD
Bosentan—Pain—Doxorubicin—sarcoma	0.000154	0.00051	CcSEcCtD
Bosentan—Abdominal pain—Epirubicin—sarcoma	0.000153	0.00051	CcSEcCtD
Bosentan—Body temperature increased—Epirubicin—sarcoma	0.000153	0.00051	CcSEcCtD
Bosentan—Gastrointestinal pain—Doxorubicin—sarcoma	0.000147	0.000488	CcSEcCtD
Bosentan—Hypersensitivity—Epirubicin—sarcoma	0.000143	0.000475	CcSEcCtD
Bosentan—Urticaria—Doxorubicin—sarcoma	0.000143	0.000474	CcSEcCtD
Bosentan—Body temperature increased—Doxorubicin—sarcoma	0.000142	0.000471	CcSEcCtD
Bosentan—Abdominal pain—Doxorubicin—sarcoma	0.000142	0.000471	CcSEcCtD
Bosentan—Asthenia—Epirubicin—sarcoma	0.000139	0.000462	CcSEcCtD
Bosentan—Pruritus—Epirubicin—sarcoma	0.000137	0.000456	CcSEcCtD
Bosentan—Diarrhoea—Epirubicin—sarcoma	0.000133	0.000441	CcSEcCtD
Bosentan—Hypersensitivity—Doxorubicin—sarcoma	0.000132	0.000439	CcSEcCtD
Bosentan—Asthenia—Doxorubicin—sarcoma	0.000129	0.000428	CcSEcCtD
Bosentan—Dizziness—Epirubicin—sarcoma	0.000128	0.000426	CcSEcCtD
Bosentan—Pruritus—Doxorubicin—sarcoma	0.000127	0.000422	CcSEcCtD
Bosentan—Vomiting—Epirubicin—sarcoma	0.000123	0.00041	CcSEcCtD
Bosentan—Diarrhoea—Doxorubicin—sarcoma	0.000123	0.000408	CcSEcCtD
Bosentan—Rash—Epirubicin—sarcoma	0.000122	0.000406	CcSEcCtD
Bosentan—Dermatitis—Epirubicin—sarcoma	0.000122	0.000406	CcSEcCtD
Bosentan—Headache—Epirubicin—sarcoma	0.000122	0.000404	CcSEcCtD
Bosentan—Dizziness—Doxorubicin—sarcoma	0.000119	0.000394	CcSEcCtD
Bosentan—Nausea—Epirubicin—sarcoma	0.000115	0.000383	CcSEcCtD
Bosentan—Vomiting—Doxorubicin—sarcoma	0.000114	0.000379	CcSEcCtD
Bosentan—Rash—Doxorubicin—sarcoma	0.000113	0.000376	CcSEcCtD
Bosentan—Dermatitis—Doxorubicin—sarcoma	0.000113	0.000376	CcSEcCtD
Bosentan—Headache—Doxorubicin—sarcoma	0.000113	0.000374	CcSEcCtD
Bosentan—Nausea—Doxorubicin—sarcoma	0.000107	0.000354	CcSEcCtD
